Literature DB >> 33161736

Daily intake of probiotic strain Bacillus subtilis DE111 supports a healthy microbiome in children attending day-care.

A Paytuví-Gallart1, W Sanseverino1, A M Winger2.   

Abstract

There is ample evidence suggesting that modulations in gut microbiota play an important role in inflammation and immunity. In particular, the microbiota of children is highly susceptible to environment influences, such as infections. Consequently, probiotics and their ability to promote and support a healthy microbiome have been increasingly studied. This study aimed at investigating the effects of a probiotic supplement (Bacillus subtilis DE111) on the microbiome composition of preschool aged children attending day care. Healthy children aged 2-6 years old were randomised to receive either probiotic or placebo once a day for 8 weeks. No significant changes of the overall microbiome equilibrium were seen in between the two groups or from baseline to week 8. However, alpha diversity was increased in the probiotic group from baseline to week 8 (P<0.05), with no change in the placebo group. A decrease in the Firmicutes/Bacteroidetes ratio following probiotic supplementation (P<0.05) was also observed. Differential abundance analysis revealed an increase in Alistepes (P<0.01), Bacteroides (P<0.05), Parabacteroides (P<0.01), Odoribacter (P<0.001) and Rikenellaceae (P<0.001) in the probiotic group, most of which are involved in inflammation reduction. In addition, a decrease in Eisenbergiella (P<0.001), Lactobacillales (P<0.01) and Streptococcaceae (P<0.01), which is considered pro-inflammatory, were also observed in the probiotic group. Together with a reduction of the F/B ratio observed in the probiotic group, these results suggest probiotic supplementation with Bacillus subtilis DE111 introduce subtle but positive changes in the microbiome of children aged 2-6 years old.

Entities:  

Keywords:  Bacillus subtilis DE111; gut microbiome; paediatric population

Mesh:

Year:  2020        PMID: 33161736     DOI: 10.3920/BM2020.0022

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  5 in total

1.  Preclinical Safety Assessment of Bacillus subtilis BS50 for Probiotic and Food Applications.

Authors:  Laura M Brutscher; Claudia Borgmeier; Sean M Garvey; Jessica L Spears
Journal:  Microorganisms       Date:  2022-05-17

2.  Examining the Gastrointestinal and Immunomodulatory Effects of the Novel Probiotic Bacillus subtilis DE111.

Authors:  Kimberley E Freedman; Jessica L Hill; Yuren Wei; Allegra R Vazquez; Diana S Grubb; Roxanne E Trotter; Scott D Wrigley; Sarah A Johnson; Michelle T Foster; Tiffany L Weir
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

3.  Safety Assessment of Bacillus subtilis MB40 for Use in Foods and Dietary Supplements.

Authors:  Jessica L Spears; Richard Kramer; Andrey I Nikiforov; Marisa O Rihner; Elizabeth A Lambert
Journal:  Nutrients       Date:  2021-02-25       Impact factor: 5.717

Review 4.  The Impact of Probiotic Bacillus subtilis on Injurious Behavior in Laying Hens.

Authors:  Sha Jiang; Jia-Ying Hu; Heng-Wei Cheng
Journal:  Animals (Basel)       Date:  2022-03-30       Impact factor: 2.752

5.  Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis.

Authors:  Dušan Radojević; Marina Bekić; Alisa Gruden-Movsesijan; Nataša Ilić; Miroslav Dinić; Aleksandar Bisenić; Nataša Golić; Dragana Vučević; Jelena Đokić; Sergej Tomić
Journal:  Gut Microbes       Date:  2022 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.